1. Home
  2. RDY vs HI Comparison

RDY vs HI Comparison

Compare RDY & HI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
  • HI
  • Stock Information
  • Founded
  • RDY 1984
  • HI 2007
  • Country
  • RDY India
  • HI United States
  • Employees
  • RDY N/A
  • HI N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • HI Miscellaneous manufacturing industries
  • Sector
  • RDY Health Care
  • HI Consumer Discretionary
  • Exchange
  • RDY Nasdaq
  • HI Nasdaq
  • Market Cap
  • RDY 2.5B
  • HI 2.4B
  • IPO Year
  • RDY N/A
  • HI N/A
  • Fundamental
  • Price
  • RDY $14.81
  • HI $35.10
  • Analyst Decision
  • RDY Buy
  • HI Buy
  • Analyst Count
  • RDY 1
  • HI 2
  • Target Price
  • RDY $17.00
  • HI $36.50
  • AVG Volume (30 Days)
  • RDY 1.9M
  • HI 411.2K
  • Earning Date
  • RDY 01-23-2025
  • HI 02-03-2025
  • Dividend Yield
  • RDY 3.89%
  • HI 2.56%
  • EPS Growth
  • RDY 4.63
  • HI N/A
  • EPS
  • RDY 0.76
  • HI N/A
  • Revenue
  • RDY $3,579,112,656.00
  • HI $3,182,800,000.00
  • Revenue This Year
  • RDY $16.39
  • HI N/A
  • Revenue Next Year
  • RDY $8.74
  • HI $4.10
  • P/E Ratio
  • RDY $19.50
  • HI N/A
  • Revenue Growth
  • RDY 12.37
  • HI 12.63
  • 52 Week Low
  • RDY $13.52
  • HI $25.11
  • 52 Week High
  • RDY $16.89
  • HI $50.58
  • Technical
  • Relative Strength Index (RSI)
  • RDY 42.14
  • HI 72.32
  • Support Level
  • RDY $14.74
  • HI $30.25
  • Resistance Level
  • RDY $14.94
  • HI $31.79
  • Average True Range (ATR)
  • RDY 0.20
  • HI 0.85
  • MACD
  • RDY -0.12
  • HI 0.46
  • Stochastic Oscillator
  • RDY 7.32
  • HI 97.08

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About HI Hillenbrand Inc

Hillenbrand Inc is a U.S.-based company that operates through two segments. The Advanced Process Solutions segment designs, develops, manufactures, and services engineered industrial equipment. The Molding Technology Solutions segment offers engineered and customized systems in plastic technology and processing. It earns it revenue from Advanced Process Solutions, and Geographically from America, following by Asia and EMEA.

Share on Social Networks: